Joseph M. Lobacki's most recent trade in Sutro Biopharma Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Joseph M. Lobacki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Joseph M. Lobacki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Joseph M. Lobacki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Joseph M. Lobacki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Joseph M. Lobacki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 18,500 | 18,500 | - | - | Stock Option (right to buy) |